Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

A review published in JAMA Ophthalmology uncovered at least nine cases of patients who experienced vision loss ... or tirzepatide, the active ingredients in Wegovy and Zepbound, respectively.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

and tirzepatide, sold as Mounjaro and Zepbound. These medications, initially used to treat diabetes, have gained significant popularity due to their effectiveness in promoting weight loss. The study ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.